Douglas John Karas serves as Executive at Nascent Biotech Inc., where they oversee executive responsibilities. Since joining the company, Douglas John Karas has executed 15 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 31, 2024 involved transacting 27,100 shares valued at $4.9K.
Douglas John Karas currently holds 1,771,552 shares of Nascent Biotech Inc. (NBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas John Karas has been a net buyer of NBIO stock. They have purchased $10.0K and sold $0 worth of shares.
Douglas John Karas's most recent insider trade was on Mar 31, 2024, when they sold 27,100 shares at $0.18 per share.
Get notified when new Form 4 filings are submitted
| $0.18 |
| Discretionary |
| Sep 29, 2023 | NBIO | $5.2K | Other | 39,750 | $0.13 | Discretionary |
| Mar 31, 2023 | NBIO | $5.4K | Other | 89,285 | $0.06 | Discretionary |
| Dec 30, 2022 | NBIO | $5.0K | Other | 25,000 | $0.20 | Discretionary |
| Mar 9, 2022 | NBIO | $15.0K | Other | 300,000 | $0.05 | Discretionary |
| Jun 30, 2021 | NBIO | $9.2K | Other | 83,334 | $0.11 | Discretionary |
| Apr 9, 2021 | NBIO | $24.6K | Other | 307,010 | $0.08 | Discretionary |
| Mar 31, 2021 | NBIO | $5.8K | Other | 83,334 | $0.07 | Discretionary |
| Dec 31, 2020 | NBIO | $5.4K | Other | 108,460 | $0.05 | Discretionary |
| Nov 20, 2020 | NBIO | $17.5K | Other | 350,000 | $0.05 | Discretionary |
| Sep 30, 2020 | NBIO | $5.0K | Other | 71,430 | $0.07 | Discretionary |
| Jun 25, 2019 | NBIO | $9.5K | Other | 50,000 | $0.19 | Discretionary |
| Aug 14, 2017 | NBIO | $11.0K | Other | 50,000 | $0.22 | Discretionary |
| Apr 3, 2015 | NBIO | $10.0K | Purchase | 10,000 | $1.00 | Discretionary |